Late-stage ovarian cancer therapy shows promise in phase II trial
Wednesday, August 3, 2011 - 13:30
in Health & Medicine
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.